Interstitial lung disease (ILD) refers to a group of disorders characterized by inflammation and scarring of the lung tissue, impairing its ability to function properly. Here are key points about interstitial lung disease:

• ILD encompasses various conditions affecting the interstitium, the tissue surrounding the air sacs in the lungs, leading to symptoms such as cough, shortness of breath, fatigue, and unexplained weight loss.
• Causes of ILD include exposure to environmental toxins, occupational hazards, autoimmune diseases, infections, and certain medications.
• Diagnosis involves a thorough medical history, physical examination, lung function tests, imaging studies such as chest X-rays and high-resolution CT scans, and sometimes lung biopsy to confirm the specific type of ILD.
• Treatment for ILD aims to manage symptoms, slow disease progression, and improve quality of life through medications such as corticosteroids, immunosuppressants, and antifibrotic agents, as well as oxygen therapy and pulmonary rehabilitation.
• In severe cases, lung transplantation may be considered as a treatment option for individuals with advanced ILD and significant respiratory impairment. Early detection, prompt intervention, and ongoing monitoring are essential for optimizing outcomes in patients with interstitial lung disease.